Literature DB >> 15111177

Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.

Guo-Qing Wang1, Guang-Gen Jiao, Fu-Bao Chang, Wei-Hong Fang, Jin-Xiang Song, Ning Lu, Dong-Mei Lin, Yong-Qiang Xie, Ling Yang.   

Abstract

BACKGROUND: Cancer of the esophagus is one of the most commonly seen malignancies in China. From 1959 to 1981, mass screening of esophageal cancer disclosed that the age-adjusted incidence in the 40- to 69-year-old population in Lin County, Henan Province, was 470/10(5) In its northern part, an even higher incidence of 760/10(5)was found. As they were discovered by mass screening, most of them were found to have early lesions. Surgical treatment was done in attempt to find out the feasibility of managing esophageal carcinoma by early diagnosis and early treatment. This paper is the result of the long-term follow-up.
METHODS: Since 1972, a total of 17 extensive mass screening has been conducted among more than 160,000 participants in the rural areas in Henan, Hebei, and northern Jiangsu provinces, sorting out more than 30,000 high-risk individuals. Among these individuals, 24,600 were examined by endoscopy, discovering 2,094 patients with carcinomas in the esophagus or gastric cardia; 757 of these 2,094 patients were found to have superficial esophageal cancer; 420 patients accepted surgical treatment. Esophagectomy with gastric replacement was performed through left thoracotomy in all patients. Cervical anastomosis 94 (22.4%), intrathoracic supraaortic anastomosis 307 (73.1%), and infra-aortic anastomosis 19 (4.5%) were done. Double thoracoabdominal lymphatic dissection was performed.
RESULTS: The resection rate was 100%. One-month operative mortality occurred in 5 (1.2%). Postoperative complications developed and were satisfactorily treated in 28 patients (6.7%). Pathology of the cancer specimens showed that there were carcinoma in situ in 76 (all without lymphatic metastasis), intramucosal (TI) carcinoma in 126 (2 [1.6%] with lymphatic metastasis), and submucous infiltrating (TI) carcinoma in 218 (34 [15.6%] with lymphatic metastasis). All these 420 patients have been followed up to 2001 with a follow-up rate of 94.1%. Those who were lost to follow-up were taken as censored cases. The survival rates were calculated by the life-table method. The 5-, 10-, 15-, 20-, and 25-year survival rates were 86.14%, 75.03%, 64.48%, 56.17%, and 49.93%, respectively.
CONCLUSIONS: Esophageal balloon cytology, endoscopy, mucosa 1.2% iodine stain, and multipoint biopsy may be the best approach for early diagnosis of esophageal carcinoma. Surgical resection of superficial esophageal cancer provides excellent long-term survival with acceptable quality of life. It was discovered that carcinoma in situ and intramucosal carcinoma gave far better results than the submucosal infiltrative carcinoma, as the latter tends to have a higher frequency of lymphatic metastasis.

Entities:  

Mesh:

Year:  2004        PMID: 15111177     DOI: 10.1016/j.athoracsur.2003.10.098

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  67 in total

1.  Multidisciplinary approach to oesophageal cancer.

Authors:  F López
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

2.  Population-based study of DNA image cytometry as screening method for esophageal cancer.

Authors:  Lin Zhao; Wen-Qiang Wei; De-Li Zhao; Chang-Qing Hao; Dong-Mei Lin; Qin-Jing Pan; Xin-Qing Li; Fu-Hua Lei; Jin-Wu Wang; Guo-Qing Wang; Qi Shang; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

3.  Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China.

Authors:  Juan Yang; Wen-Qiang Wei; Jin Niu; Zhi-Cai Liu; Chun-Xia Yang; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

4.  Serum miRNA expression in patients with esophageal squamous cell carcinoma.

Authors:  Beina Hui; Xin Chen; Lingyun Hui; Ruxing Xi; Xiaozhi Zhang
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

5.  Endoscopic mucosal resection in the setting of Barrett's esophagus.

Authors:  Jason K Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

6.  Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Authors:  Philip R Taylor; Christian C Abnet; Sanford M Dawsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

7.  Incidence and mortality rate of esophageal cancer has decreased during past 40 years in Hebei Province, China.

Authors:  Yutong He; Yan Wu; Guohui Song; Yongwei Li; Di Liang; Jing Jin; Denggui Wen; Baoen Shan
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

8.  Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.

Authors:  D Boller; P Spieler; R Schoenegg; J Neuweiler; D Kradolfer; R Studer; R Grossenbacher; U Zuercher; C Meyenberger; J Borovicka
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

9.  Functional outcome of gastrointestinal tract and quality of life after esophageal reconstruction of esophagus cancer.

Authors:  Manochehr Aghajanzadeh; Feizollah Safarpour; M Reza Koohsari; Farborz M Ghanaei; Sadigheh M Bodaghi; Hadi Tozandehgani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 10.  Minimally invasive surgery and cancer: controversies part 1.

Authors:  Melanie Goldfarb; Steven Brower; S D Schwaitzberg
Journal:  Surg Endosc       Date:  2009-07-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.